Biochemistry and clinical applications of ribavirin.
D000328:Adult; D000336:Aerosols; D000818:Animals; D000998:Antiviral Agents / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007168:IMP Dehydrogenase / Q000037:antagonists & inhibitors; D007223:Infant; D007231:Infant, Newborn; D007251:Influenza, Human / Q000188:drug therapy; D007700:Kinetics; D008457:Measles / Q000188:drug therapy; D009975:Orthomyxoviridae / Q000187:drug effects / Q000235:genetics; D018184:Paramyxoviridae Infections / Q000188:drug therapy; D012333:RNA, Messenger / Q000378:metabolism; D012367:RNA, Viral / Q000378:metabolism; D011897:Random Allocation; D012136:Respiratory Syncytial Viruses / Q000187:drug effects; D010253:Respirovirus Infections / Q000188:drug therapy; D012254:Ribavirin / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D012263:Ribonucleosides / Q000494:pharmacology*
D000336:Aerosols; D000998:Antiviral Agents; D012333:RNA, Messenger; D012367:RNA, Viral; D012263:Ribonucleosides; D012254:Ribavirin; D007168:IMP Dehydrogenase